Base4innovation Ltd was formed in 2007 by Cameron Frayling with support from the University of Warwick with the aim of developing a new high-speed, low-cost method of DNA sequencing combining well-known techniques such as single-photon detection, fluorescent labelling and DNA electrophoresis with plasmonic nanostructures and cutting-edge methods of nanofabrication.

Management

David Oxlade: Chairman, previously CEO of Xenova and President of Syva Co.

Cameron Frayling: CEO, Inventor, Researcher at the University of Warwick.

Peter Cunliffe: Financial Director, Company Secretary.

Ederyn Williams: Non-Executive Director, Director of Warwick Ventures of the University of Warwick.

Scientific Advisors

Jeremy Baumberg: Professor in Physics, Cambridge University, Director of Cambridge Nanophotonics Group, Founder of Mesophotonics

Robert Old: Reader in Biological Sciences, University of Warwick

John Sulston: Former Director of the Wellcome Trust Sanger Institute, member of the Human Genome Project, shared the Nobel prize for Physiology or Medicine (2002).

Robert Taylor: Reader in Physics, University of Oxford